Lacosta, A., Pascual-Lucas, M., Pesini, P., Casabona, D., Pérez-Grijalba, V., Marcos-Campos, I., . . . Sarasa, M. (2018). Safety, tolerability and immunogenicity of an active anti-Aβ(40) vaccine (ABvac40) in patients with Alzheimer’s disease: A randomised, double-blind, placebo-controlled, phase I trial. Alzheimers Res Ther.
Chicago-tyylinen lähdeviittausLacosta, Ana-María, et al. "Safety, Tolerability and Immunogenicity of an Active Anti-Aβ(40) Vaccine (ABvac40) in Patients With Alzheimer’s Disease: A Randomised, Double-blind, Placebo-controlled, Phase I Trial." Alzheimers Res Ther 2018.
MLA-viiteLacosta, Ana-María, et al. "Safety, Tolerability and Immunogenicity of an Active Anti-Aβ(40) Vaccine (ABvac40) in Patients With Alzheimer’s Disease: A Randomised, Double-blind, Placebo-controlled, Phase I Trial." Alzheimers Res Ther 2018.